Serious riskFDA DrugClass I

Baxter Cefazolin in Dextrose injection recalled for particulate matter

Baxter Healthcare Corporation is recalling one lot of Cefazolin in Dextrose injection due to the presence of particulate matter in the solution. The affected product is a frozen premix infusion bag used for intravenous antibiotic treatment. This is a Class I recall, the most serious classification.

From the FDA notice · Read the official notice ↗ · All Baxter recalls

What to do

  1. Check your facility's supply for lot #LD175708 (expiration 14-Feb-2027, NDC 0338-3508-41).
  2. Do not use affected bags. Quarantine and return them to your supplier or Baxter.
  3. Contact Baxter or the FDA if you have questions or have already administered product from this lot.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
19,032 bags
Illnesses reported
None reported
Manufactured in
1 Baxter Pkwy, Deerfield, IL, United States
Classification
Class I
Recall number
D-0787-2026

In the FDA's words

Description
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41. Presence of Particulate Matter Lot # LD175708, Exp Date: 14-Feb-2027. Distribution: US Nationwide. Affected quantity: 19,032 bags
Hazard
Presence of Particulate Matter

More from Baxter

See all

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug